Skip to main content

Table 1 General, auxological and endocrinological characteristics of our patients

From: Long-term auxological and endocrinological evaluation of patients with 9p trisomy: a focus on the growth hormone-insulin-like growth factor-I axis

Main characteristics

Case 1

Case 2

Case 3

Case 4

Sex (Female: Male)

F

F

M

F

Parental age, yrs^ (Mother: Father)

25:26

33:36

25:28

34:36

Target height, cm (SDS)

162.6 (0.1 SDS)

159 (-0.5 SDS).

166.8 (- 1.2 SDS)

159.5 (-0.5 SDS)

Gestation (weeks)

uncomplicated (41)

uncomplicated (40)

uncomplicated (40)

uncomplicated (39.4)

Birth-weight, gr (SDS)

2.650 (-2.4)

2.850 (-1.6)

3.140 (0.3 SDS)

2.370 (-1.6 SDS)

Birth-length, cm (SDS)

45 (-3.2)

46 (-2.4)

49 (-0.4 SDS)

45 (-2.4 SDS)

OFC, cm (SDS)

34 (-0.5)

-

33 (-1.1 SDS).

32 (-1.6 SDS)

Neuromotor development

Delayed

Moderately delayed

Delayed

Delayed

9p trisomy diagnosis

At birth

7 months

3 years 9 months

2 years 2 months

Chromosomal study

47,XX, t (9; 14) (q12; p11.1), +der (9)t(9;14) (q12; p11.1) [24]

46,XX,-9, dup (9) (p12; p22) [24]

46,XY, der (22)t(9;22)(p21; p12). [24]

46,XX, dup(9)(p24.3-p13.3)

Postnatal growth delay

Yes

Yes

Yes

Yes

GH stimulation tests (type)*

(C) - (A)

(A) - (C)

(GA) - (C)

(C) - (GA)

 

Basal GH level (ng/mL)

0.9 - 1.3

1.7 - 0.2

0.7 - 1.1

0.4 - 0.5

 

Peak GH level (ng/mL)

7.0 - 7.4

5.0 – 13.0

6.3 – 4.3

9.6 – 8.8

GH axis dysfunction type

GHD

GHNSD

GHD

GHD

GH treatment (Y:N)

Yes

Yes

No

No

Puberty onset, B2 or G2 (yrs)

11.2

14.5

14.8

-

 

B3 or G3

11.9

15.6

16.2

-

 

B4 or G4

12.9

16.9

17.5

-

Final height, cm (SDS)

156.9 (-0.9 SDS).

154.4 (-1.3 SDS)

157.5 (-2.6 SDS)

-

  1. OFC: Occipito-Frontal head Circumference; GH: Growth Hormone; GHD: Growth Hormone Deficiency; GHNSD: Growth Hormone Neurosecretory Dysfunction.
  2. * (A) = arginine; (C) = clonidine; (GA) = GHRH + arginine; ^At conception.